RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 158 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SG Americas Securities, LLC | 55,010 | $367 | 0.00% |
| Aquatic Capital Management LLC | 9,300 | $62 | 0.00% |
| Nuveen Asset Management, LLC | 1,025,585 | $6,840 | 0.00% |
| IEQ CAPITAL, LLC | 17,920 | $119,526 | 0.00% |
| Ameritas Investment Partners, Inc. | 10,141 | $67,640 | 0.00% |
| ALBION FINANCIAL GROUP /UT | 4,183 | $27,901 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 345,540 | $2,304 | 0.00% |
| MARTINGALE ASSET MANAGEMENT L P | 25,400 | $169,418 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 5,502 | $36,698 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 7,549 | $50,352 | 0.00% |
| CITIGROUP INC | 688,225 | $4,590,461 | 0.00% |
| FMR LLC | 9,510,922 | $63,437,846 | 0.00% |
| Tower Research Capital LLC (TRC) | 14,944 | $100 | 0.00% |
| Vident Investment Advisory, LLC | 16,133 | $107,607 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 65,956 | $439,927 | 0.00% |
| Point72 Middle East FZE | 13,376 | $89,219 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 50,350 | $336 | 0.00% |
| Verition Fund Management LLC | 33,400 | $222,778 | 0.00% |
| STATE STREET CORP | 6,372,515 | $42,504,675 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 646,610 | $4,313 | 0.00% |
External links
This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q1 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.